---
document_datetime: 2025-11-23 14:51:47
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/pramipexole-accord.html
document_name: pramipexole-accord.html
version: success
processing_time: 0.0953888
conversion_datetime: 2025-12-24 22:52:34.693495
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Pramipexole Accord

[RSS](/en/individual-human-medicine.xml/66572)

##### Withdrawn

This medicine's authorisation has been withdrawn

pramipexole

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 13 April 2022, the European Commission withdrew the marketing authorisation for Pramipexole Accord (pramipexole) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Accord Healthcare S.L.U., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Pramipexole Accord was granted marketing authorisation in the EU on 30 September 2011 for the treatment of idiopathic Parkinson's disease and restless legs syndrome. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2016.

Pramipexole Accord is a generic medicine of Mirapexin. There are other generic medicinal products of Mirapexin authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Pramipexole Accord is updated to indicate that the marketing authorisation is no longer valid.

Pramipexole Accord : EPAR - Summary for the public

Reference Number: EMA/684920/2011

English (EN) (146.77 KB - PDF)

**First published:** 19/10/2011

**Last updated:** 11/03/2024

[View](/en/documents/overview/pramipexole-accord-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-968)

български (BG) (208.42 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/bg/documents/overview/pramipexole-accord-epar-summary-public_bg.pdf)

español (ES) (149.81 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/es/documents/overview/pramipexole-accord-epar-summary-public_es.pdf)

čeština (CS) (185.16 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/cs/documents/overview/pramipexole-accord-epar-summary-public_cs.pdf)

dansk (DA) (144.06 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/da/documents/overview/pramipexole-accord-epar-summary-public_da.pdf)

Deutsch (DE) (155.06 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/de/documents/overview/pramipexole-accord-epar-summary-public_de.pdf)

eesti keel (ET) (139.54 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/et/documents/overview/pramipexole-accord-epar-summary-public_et.pdf)

ελληνικά (EL) (213.09 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/el/documents/overview/pramipexole-accord-epar-summary-public_el.pdf)

français (FR) (152.96 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/fr/documents/overview/pramipexole-accord-epar-summary-public_fr.pdf)

hrvatski (HR) (172.55 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/hr/documents/overview/pramipexole-accord-epar-summary-public_hr.pdf)

italiano (IT) (148.43 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/it/documents/overview/pramipexole-accord-epar-summary-public_it.pdf)

latviešu valoda (LV) (180.6 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/lv/documents/overview/pramipexole-accord-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (178.89 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/lt/documents/overview/pramipexole-accord-epar-summary-public_lt.pdf)

magyar (HU) (177.23 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/hu/documents/overview/pramipexole-accord-epar-summary-public_hu.pdf)

Malti (MT) (187.7 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/mt/documents/overview/pramipexole-accord-epar-summary-public_mt.pdf)

Nederlands (NL) (152.9 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/nl/documents/overview/pramipexole-accord-epar-summary-public_nl.pdf)

polski (PL) (189.47 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/pl/documents/overview/pramipexole-accord-epar-summary-public_pl.pdf)

português (PT) (151.59 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/pt/documents/overview/pramipexole-accord-epar-summary-public_pt.pdf)

română (RO) (184.94 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/ro/documents/overview/pramipexole-accord-epar-summary-public_ro.pdf)

slovenčina (SK) (178.48 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sk/documents/overview/pramipexole-accord-epar-summary-public_sk.pdf)

slovenščina (SL) (178.52 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sl/documents/overview/pramipexole-accord-epar-summary-public_sl.pdf)

Suomi (FI) (139.62 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/fi/documents/overview/pramipexole-accord-epar-summary-public_fi.pdf)

svenska (SV) (144.74 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sv/documents/overview/pramipexole-accord-epar-summary-public_sv.pdf)

## Product information

Pramipexole Accord : EPAR - Product Information

English (EN) (1.23 MB - PDF)

**First published:** 19/10/2011

**Last updated:** 11/03/2024

[View](/en/documents/product-information/pramipexole-accord-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-21)

български (BG) (1.78 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/bg/documents/product-information/pramipexole-accord-epar-product-information_bg.pdf)

español (ES) (1.36 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/es/documents/product-information/pramipexole-accord-epar-product-information_es.pdf)

čeština (CS) (1.49 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/cs/documents/product-information/pramipexole-accord-epar-product-information_cs.pdf)

dansk (DA) (1.31 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/da/documents/product-information/pramipexole-accord-epar-product-information_da.pdf)

Deutsch (DE) (1.38 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/de/documents/product-information/pramipexole-accord-epar-product-information_de.pdf)

eesti keel (ET) (1.33 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/et/documents/product-information/pramipexole-accord-epar-product-information_et.pdf)

ελληνικά (EL) (1.87 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/el/documents/product-information/pramipexole-accord-epar-product-information_el.pdf)

français (FR) (1.49 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/fr/documents/product-information/pramipexole-accord-epar-product-information_fr.pdf)

hrvatski (HR) (1.44 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/hr/documents/product-information/pramipexole-accord-epar-product-information_hr.pdf)

íslenska (IS) (1.28 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/is/documents/product-information/pramipexole-accord-epar-product-information_is.pdf)

italiano (IT) (1.42 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/it/documents/product-information/pramipexole-accord-epar-product-information_it.pdf)

latviešu valoda (LV) (1.56 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/lv/documents/product-information/pramipexole-accord-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.57 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/lt/documents/product-information/pramipexole-accord-epar-product-information_lt.pdf)

magyar (HU) (1.41 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/hu/documents/product-information/pramipexole-accord-epar-product-information_hu.pdf)

Malti (MT) (1.6 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/mt/documents/product-information/pramipexole-accord-epar-product-information_mt.pdf)

Nederlands (NL) (1.29 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/nl/documents/product-information/pramipexole-accord-epar-product-information_nl.pdf)

norsk (NO) (1.25 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/no/documents/product-information/pramipexole-accord-epar-product-information_no.pdf)

polski (PL) (1.58 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/pl/documents/product-information/pramipexole-accord-epar-product-information_pl.pdf)

português (PT) (1.16 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/pt/documents/product-information/pramipexole-accord-epar-product-information_pt.pdf)

română (RO) (1.62 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/ro/documents/product-information/pramipexole-accord-epar-product-information_ro.pdf)

slovenčina (SK) (1.47 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sk/documents/product-information/pramipexole-accord-epar-product-information_sk.pdf)

slovenščina (SL) (1.47 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sl/documents/product-information/pramipexole-accord-epar-product-information_sl.pdf)

Suomi (FI) (1.33 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/fi/documents/product-information/pramipexole-accord-epar-product-information_fi.pdf)

svenska (SV) (1.25 MB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sv/documents/product-information/pramipexole-accord-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0017 20/11/2020

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Pramipexole Accord : EPAR - All Authorised presentations

English (EN) (43.27 KB - PDF)

**First published:** 19/10/2011

**Last updated:** 11/03/2024

[View](/en/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-817)

български (BG) (89.32 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/bg/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_bg.pdf)

español (ES) (40.78 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/es/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_es.pdf)

čeština (CS) (51.83 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/cs/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (40.13 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/da/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (39.87 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/de/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (40.21 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/et/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (84.8 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/el/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_el.pdf)

français (FR) (41.29 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/fr/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (89.03 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/hr/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (39.65 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/is/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_is.pdf)

italiano (IT) (38.98 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/it/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (71.58 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/lv/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (74.02 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/lt/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (74.32 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/hu/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (68.78 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/mt/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (36.97 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/nl/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (39.18 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/no/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_no.pdf)

polski (PL) (53.67 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/pl/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_pl.pdf)

português (PT) (40.3 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/pt/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_pt.pdf)

română (RO) (74.43 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/ro/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (54.97 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sk/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (39.73 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sl/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (37.64 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/fi/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (39.84 KB - PDF)

**First published:**

19/10/2011

**Last updated:**

11/03/2024

[View](/sv/documents/all-authorised-presentations/pramipexole-accord-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Pramipexole Accord Active substance pramipexole dihydrochloride monohydrate International non-proprietary name (INN) or common name pramipexole Therapeutic area (MeSH)

- Parkinson Disease
- Restless Legs Syndrome

Anatomical therapeutic chemical (ATC) code N04BC05

### Pharmacotherapeutic group

Anti-Parkinson drugs

### Therapeutic indication

Pramipexole Accord is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end-of-dose or 'on-off' fluctuations).

## Authorisation details

EMA product number EMEA/H/C/002291

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Accord Healthcare S.L.U.

Edificio Este Planta 6a

Opinion adopted 21/07/2011 Marketing authorisation issued 29/09/2011 Withdrawal of marketing authorisation 13/04/2022 Revision 10

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Pramipexole Accord : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (387.79 KB - PDF)

**First published:** 26/02/2013

**Last updated:** 11/03/2024

[View](/en/documents/procedural-steps-after/pramipexole-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Pramipexole Accord : EPAR - Public assessment report

Adopted

Reference Number: EMA/816841/2011

English (EN) (550.56 KB - PDF)

**First published:** 19/10/2011

**Last updated:** 11/03/2024

[View](/en/documents/assessment-report/pramipexole-accord-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Pramipexole Accord

Adopted

Reference Number: EMA/CHMP/507521/2011

English (EN) (83.63 KB - PDF)

**First published:** 22/07/2011

**Last updated:** 11/03/2024

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-pramipexole-accord_en.pdf)

**This page was last updated on** 11/03/2024

## Share this page

[Back to top](#main-content)